Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Be...
Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway
About this item
Full title
Author / Creator
Ebrahim, Nesrine , Al Saihati, Hajir A. , Mostafa, Ola , Hassouna, Amira , Abdulsamea, Sameh , Abd El Aziz M. El Gebaly, Eman , Abo-Rayah, Nashwa Hassan , Sabry, Dina , El-Sherbiny, Mohamed , Madboly, Abdelmonem G. , Hussien, Noha Ibrahim , Saadani, Raja El Hasnaoui , Ebrahim, Hasnaa Ali , Badr, Omnia A. M. , Elsherbiny, Nehal M. and Salim, Rabab F.
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Trastuzumab (Trz) is a humanized monoclonal antibody targeting epidermal growth factor receptor 2 (HER2; ErbB2). The combined administration of Trz and doxorubicin (DOX) has shown potent anti-cancer efficacy; however, this regimen may be accompanied by severe cardiac toxicity. Mesenchymal stem cells (MSCs)-derived exosomes are nanosized vesicles th...
Alternative Titles
Full title
Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway
Authors, Artists and Contributors
Author / Creator
Al Saihati, Hajir A.
Mostafa, Ola
Hassouna, Amira
Abdulsamea, Sameh
Abd El Aziz M. El Gebaly, Eman
Abo-Rayah, Nashwa Hassan
Sabry, Dina
El-Sherbiny, Mohamed
Madboly, Abdelmonem G.
Hussien, Noha Ibrahim
Saadani, Raja El Hasnaoui
Ebrahim, Hasnaa Ali
Badr, Omnia A. M.
Elsherbiny, Nehal M.
Salim, Rabab F.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9181089
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9181089
Other Identifiers
ISSN
1422-0067,1661-6596
E-ISSN
1422-0067
DOI
10.3390/ijms23115967